Please select the option that best describes you:

Do you have different hotspot and heterogeneity goals for SBRT of ground glass lesions vs more solid adenocarcinoma NSCLC lesions?  

E.g. higher central hotspot in solid lesions? Any data on differences in toxicity?



Answer from: Radiation Oncologist at Academic Institution
Sign in or Register to read more